>>> TradeGate Pre-Market Indications

DAX:
  • SAP (SAP TH) +2.1%
  • Rheinmetall (RHM TH) +1.5%
MDAX:
  • TKMS (TKMS TH) +2%
  • Nemetschek (NEM TH) +1.5%
  • CTS Eventim (EVD TH) +1.3%
  • Redcare Pharmacy NV (RDC TH) +1.1%
  • DWS (DWS TH) +1%
  • Hensoldt (HAG TH) -1.2%
  • Delivery Hero (DHER TH) -1.9%
SDAX:
  • PNE AG (PNE3 TH) +5.2%
  • Wacker Neuson (WAC TH) +2.2%
  • Siltronic (WAF TH) +1.3%
  • Deutsche Euroshop (DEQ TH) +1.2%
  • Hamborner REIT (HABA TH) +1.1%
  • Deutsche PBB (PBB TH) -1.1%
  • Tonies SE (TNIE TH) -1.1%
  • SAF-Holland SE (SFQ TH) -1.4%
  • SFC Energy (F3C TH) -1.5%
  • Verve Group (VRV TH) -2.9%

>>> ROS AV — READ-ACROSS FROM HIAB/LABRIE M&A (deck out 1-Jun)

ROS AV — READ-ACROSS FROM HIAB/LABRIE M&A (deck out 1-Jun)

Hiab (HIAB FH) to buy Labrie Environmental Grp. Headline terms now confirmed: PP USD1,035m cash-free/debt-free = 9.2x LTM comparable EBITDA (Labrie EBITDA USD113m / 23% margin; sales USD491m = 2.11x). #1 N.Am automated side loaders, 100% N.Am, order book ~USD435m, ~1,200 staff, 4 plants. Close Q3-26. Hiab calls it margin- & growth-accretive (Labrie 23% EBITDA vs Hiab 16%); financed w/ cash + up to EUR900m debt, PF ND/EBITDA 2.1x.

KEY POINT — IGNORE THE SALES MULTIPLE. 2.11x sales transfers to a fantasy EUR3bn EV on ROS; meaningless given the margin gap (Labrie 23% vs ROS 9.5%). The real comp is EBITDA.

EV/EBITDA READ-ACROSS: deal done at 9.2x. ROS trades 6.8x EV/EBITDA LTM (EV EUR953m / EBITDA EUR139m). Re-rate ROS to the Labrie print → EV EUR1.28bn → equity ~EUR975m → ~1.5x current mkt cap (~+50%). Gap = ROS optically cheap vs a strategic W&R print.

BUT THE DISCOUNT IS LARGELY JUSTIFIED — and note the print is disciplined, not frothy: Hiab paid only 9.2x for a 23%-margin, #1-position, recurring-aftermarket franchise. ROS earns 9.5% EBITDA / 5.9% EBIT, lumpy tender-driven (airport/defence) demand vs Labrie's stable municipal replacement cycle, heavy TWC ~EUR470m, and 50.1% Robau control overhang caps the float. A firefighting bodybuilder arguably should trade below a best-in-class RCV asset. 6.8x vs 9.2x is a fair-to-modest discount, not a screaming dislocation.

TAKEAWAY: W&R/vocational-vehicle M&A is live and strategics are paying ~9x for quality. ROS re-rating case rests on self-help margin delivery (mgmt 7% EBIT by '30) + ROS-as-target optionality, NOT on closing the full gap to Labrie. Modest re-rating support, not a step-change. Comps read-across only, not a reco.

>>> Michael Burry just said Elon Musk and Nvidia's deal is built on fake numbers

Michael Burry just said Elon Musk and Nvidia's deal is built on fake numbers.

Burry published a detailed breakdown calling the entire structure "Fugazi", his word for fake.

He is alleging that billions of dollars in Nvidia chips are being hidden off balance sheets, and that American retirees are unknowingly funding the whole thing.

Nvidia, the world's largest AI chip company sold $5.4 billion worth of its most advanced GPUs, the GB200, to a company called Valor.

Valor is not a real operating business. It is a special purpose vehicle, a shell company created specifically to hold these chips and nothing else. Nvidia also invested $1.9 billion of its own money directly into Valor on top of the sale.

Those 100,000+ chips are now physically inside xAI's data center. xAI is Elon Musk's artificial intelligence company, the one that builds Grok. xAI is using every single one of those chips right now to run its AI models.

But here is what Burry is flagging.

Neither Nvidia nor xAI owns those chips on paper. Valor, the shell company holds legal title. That means $5.4 billion in GPU assets do not show up on Nvidia's balance sheet as inventory.

They do not show up on xAI's balance sheet as assets. They are legally invisible to both companies.

Nvidia gets to book the $5.4 billion as a completed sale and record it as revenue. xAI gets full use of the chips without owning them. And the risk disappears into a shell company in the middle.

Now here is where American retirees enter the picture.

Valor needed $3.5 billion in debt to fund this structure. Apollo provided it. Apollo is one of the largest asset managers on earth with $1.03 trillion under management and $834 billion specifically in private credit.

Apollo raised the $3.5 billion, packaged it into debt securities, and sold those securities to Athene.

Athene is Apollo's own insurance company. It sells fixed and indexed annuities, retirement savings products, to ordinary Americans.

When a retiree buys an Athene annuity, they believe their money is sitting in safe, stable investments. That money is now inside a structure funding Elon Musk's AI data center.

The numbers inside Athene are most alarming.

Athene holds $74.2 billion in reserves. It has moved $217 billion in assets into a captive insurer based in Bermuda, meaning those assets sit outside normal US insurance regulation and oversight.

Of the entire portfolio, 34.7%, equal to $103 billion, is classified as Level 3 assets.

Level 3 is an accounting classification that means there is no observable market price for these assets. No outside party can independently verify what they are actually worth.

The leverage sitting on top of those unpriced assets is 16 times.

Burry's says:
Every step of this structure is technically legal and publicly disclosed. But the entire thing was deliberately engineered across 8 to 12 steps to move credit risk off balance sheets and away from any market pricing.

- Nvidia books the revenue.
- Apollo collects the fees.
- xAI gets the computing power.
- And retirees sitting at the bottom of a 16x leveraged Bermuda insurance structure, holding $103 billion in assets with no market price carry the risk without knowing it exists.

>>> Barron’s weekend summary

Cover:

-In 2026, SpaceX's impending IPO is projected to value the company near $2 T and raise about $75B, positioning CEO Elon Musk to potentially become the first Taire. Despite high valuations allowing companies to remain private longer, mega-IPOs like those of SpaceX, Anthropic, OpenAI, Databricks, and Stripe pose significant risks. Historically, large IPOs have underperformed, and while investors may be eager to partake, trading is expected to be volatile. SpaceX's IPO could exceed Facebook's record market cap of $81B, highlighting the dramatic shift in public offerings.

Interview:

-No update

Tech Trader:

-Tech Trader highlighted a significant memory chip shortage initially discussed in December, linked to the surge in artificial intelligence market demands. Memory prices for PCs, smartphones, and gaming consoles are rising, with consumers facing the consequences of inflation. Major manufacturers, including Micron, SK Hynix, and Samsung, won't have new supply until mid-next year, leading to significant challenges for device makers. The average selling price of smartphones has increased by $100, with unit sales projected to decline by 14% in 2026. This environment signals an end to affordable smartphones and stresses the need for vendors to adapt to elevated prices for survival.

The Trader:

-Oil prices fell sharply in May, marking their worst month since 2020, yet shares of Occidental Petroleum appear to be a strong investment. Following a spike at the onset of the Iran war, West Texas Intermediate crude prices dropped 17% to $86.97 a barrel, while Brent crude saw a similar decline. The State Street Energy Select Sector SPDR ETF also fell 4.5%, influenced by speculation that oil prices would drop post-war. However, the expectation of high oil prices remains, as restoring normal production in the Middle East will be costly and time-consuming. Occidental Petroleum stands out among oil stocks due to its attractive valuation, trading at 10 times expected earnings and offering significant U.S.-based production, particularly in the Permian Basin. Analyst Betty Jiang upgraded Occidental to Overweight, predicting that crude prices could average $90 this year, solidifying its investment potential.

-Movado Group successfully combines dividend growth and earnings increases, recently raising its quarterly dividend to 40 cents per share, yielding 4.75%. In the first quarter, the company reported adjusted earnings of 32 cents per share, up from eight cents the previous year, with revenues increasing 4.5% to $142M. Shares surged 63% this year, contrasting with declines for major luxury brands like Richemont and LVMH. Movado benefits from a diverse portfolio that includes midtier luxury brands and licensed products, with 42% of its sales from the U.S., a robust market for luxury goods, despite challenges in the Middle East.

Features:

-Abby Miller Levy, co-founder of venture-capital firm Primetime Partners, emphasizes the importance of data in healthcare investments, focusing on longevity medicine. She applies a data-driven approach to her own health, utilizing advanced imaging and blood tests for early detection of diseases. Longevity medicine promotes continuous physiological monitoring and cutting-edge treatments to enhance life expectancy. Although not an official specialty, it is attracting various medical professionals and is supported by growing consumer interest in "biohacking." Companies like Eli Lilly and DexCom are advancing this field with innovative therapies and monitoring devices.

-Our exercise capacity naturally declines with age, peaking in our late 20s and dropping by about 1% annually thereafter. Key factors include a slowing maximum heart rate, muscle mass loss, and reduced inflammatory response, which affect overall physical ability. Dr. Amanda Paluch highlights a study linking step counts and mortality, while Dr. William Kraus notes that older individuals often compare to their previous performances rather than their best. Despite these challenges, regular exercise, particularly strength training, can significantly mitigate decline and improve overall health as one ages. Dr. Michael Joyner emphasizes the critical importance of retaining muscle strength over aerobic capacity in later years.

Europe:

-BP stock declined again after ousted chairman Albert Manifold issued a rebuttal post-removal, detailing his frugal management style. Manifold was dismissed for governance issues and stated he aimed to cut costs and streamline the company. He emphasized his personal choices, like making his own coffee and rejecting luxury perks, arguing that driving urgency in the organization differs from improper conduct. BP responded, affirming its stance and duty of care to employees affected by his behavior. As concerns over governance persist, BP's shares have fallen, including a 0.2% drop early Thursday.

Emerging Markets:

-The market is increasingly anticipating a rate hike from the Fed, influenced by a rally in equities, improving job growth, and hawkish insights from the April Federal Open Market Committee meeting. Fed Chair Kevin Warsh faces pressure as support for rate cuts appears weak among Fed members. Fed Governor Christopher Waller emphasized this shift, suggesting the easing bias should be eliminated and expressing a preference for no policy change until there is clarity on oil prices and inflation. While not advocating for a hike yet, he warned of potential hikes if inflation expectations rise, especially as the Fed nears its inflation target for the sixth consecutive year.

Commodities:

-No update

Streetwise:

-The average age of cars in the U.S. has risen to 13 years, influenced by economic conditions and changing vehicle offerings from manufacturers. Auto-parts sales have surged, with AutoZone's revenue increasing from $12.6B in 2020 to an estimated $20.5B, while O'Reilly Automotive has grown from $11.6B to an estimated $19.1B. Despite recent stock drops for both companies, analysts see potential investment opportunities. AutoZone's same-store sales grew 4.1% recently, although it missed Wall Street's expectations. Nonetheless, the company reported strong overall growth and improved operating margins, with concerns about overhead costs beginning to ease as new stores mature. The business increasingly supports professional garages, representing significant growth potential.